Addex, J&J deal

Addex disclosed in its annual R&D Day presentation that under a 2004 deal with Johnson & Johnson's Ortho-McNeil-Janssen Pharmaceuticals Inc. unit for ADX71149 the biotech is eligible for up to €111 m...